These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37878352)

  • 1. Clinical benefit of transcutaneous afferent patterned stimulation (TAPS) in essential tremor patients with high unmet need: a secondary analysis of TAPS studies.
    Isaacson SH; Pahwa R; Brillman S; Lu C; Kent AR
    Expert Rev Med Devices; 2023; 20(12):1211-1218. PubMed ID: 37878352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness of Transcutaneous Afferent Patterned Stimulation Therapy for Essential Tremor: A Randomized Pragmatic Clinical Trial.
    Dai D; Fernandes J; Kim H; Coetzer H
    Tremor Other Hyperkinet Mov (N Y); 2023; 13():38. PubMed ID: 37869579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain Metabolic Changes with Longitudinal Transcutaneous Afferent Patterned Stimulation in Essential Tremor Subjects.
    Barath AS; Rusheen AE; Min HK; Lee J; Ross E; Shin S; Loudermilk A; Wessel B; Lowe VJ; Lee KH; Blaha CD
    Tremor Other Hyperkinet Mov (N Y); 2020 Dec; 10():52. PubMed ID: 33362946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Invasive Transcutaneous Afferent Patterned Stimulation Therapy Offers Action Tremor Relief in Parkinson's Disease.
    Brillman S; Khemani P; Isaacson SH; Pahwa R; Deshpande R; Zraick V; Rajagopal A; Khosla D; Rosenbluth KH
    Tremor Other Hyperkinet Mov (N Y); 2023; 13():25. PubMed ID: 37637850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-World Evidence of Transcutaneous Afferent Patterned Stimulation for Essential Tremor.
    Brillman S; Colletta K; Borucki S; Lin PT; Waln O; Petrossian M; Khemani P; Rajagopal A; Rosenbluth KH; Khosla D
    Tremor Other Hyperkinet Mov (N Y); 2022; 12():27. PubMed ID: 36119968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential Tremor.
    Isaacson SH; Peckham E; Tse W; Waln O; Way C; Petrossian MT; Dahodwala N; Soileau MJ; Lew M; Dietiker C; Luthra N; Agarwal P; Dhall R; Morgan J; Calakos N; Zesiewicz TA; Shamim EA; Kumar R; LeWitt P; Shill HA; Simmons A; Pagan FL; Khemani P; Tate J; Maddux B; Luo L; Ondo W; Hallett M; Rajagopal A; Chidester P; Rosenbluth KH; Delp SL; Pahwa R
    Tremor Other Hyperkinet Mov (N Y); 2020 Aug; 10():29. PubMed ID: 32864188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Acute Randomized Controlled Trial of Noninvasive Peripheral Nerve Stimulation in Essential Tremor.
    Pahwa R; Dhall R; Ostrem J; Gwinn R; Lyons K; Ro S; Dietiker C; Luthra N; Chidester P; Hamner S; Ross E; Delp S
    Neuromodulation; 2019 Jul; 22(5):537-545. PubMed ID: 30701655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcutaneous Afferent Patterned Stimulation for Essential Tremor: Real-World Evidence with Long Term Follow-Up.
    Lu C; Khosla D; Kent A; Bronte-Stewart HM; Rosenbluth KH
    Tremor Other Hyperkinet Mov (N Y); 2023; 13():29. PubMed ID: 37663529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcutaneous Afferent Patterned Stimulation Therapy Reduces Hand Tremor for One Hour in Essential Tremor Patients.
    Yu JY; Rajagopal A; Syrkin-Nikolau J; Shin S; Rosenbluth KH; Khosla D; Ross EK; Delp SL
    Front Neurosci; 2020; 14():530300. PubMed ID: 33281539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations Among Tremor Amplitude, Activities of Daily Living, and Quality of Life in Patients with Essential Tremor.
    Gerbasi ME; Elble RJ; Jones E; Gillespie A; Jarvis J; Chertavian E; Smith Z; Nejati M; Shih LC
    Tremor Other Hyperkinet Mov (N Y); 2024; 14():22. PubMed ID: 38708124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcranial Direct Current Stimulation in the Treatment of Essential Tremor: An Open-Label Study.
    Helvaci Yilmaz N; Polat B; Hanoglu L
    Neurologist; 2016 Mar; 21(2):28-9. PubMed ID: 26926852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Asleep" deep brain stimulation for essential tremor.
    Chen T; Mirzadeh Z; Chapple K; Lambert M; Dhall R; Ponce FA
    J Neurosurg; 2016 Jun; 124(6):1842-9. PubMed ID: 26613177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalamic DBS with a constant-current device in essential tremor: A controlled clinical trial.
    Wharen RE; Okun MS; Guthrie BL; Uitti RJ; Larson P; Foote K; Walker H; Marshall FJ; Schwalb J; Ford B; Jankovic J; Simpson R; Dashtipour K; Phibbs F; Neimat JS; Stewart RM; Peichel D; Pahwa R; Ostrem JL;
    Parkinsonism Relat Disord; 2017 Jul; 40():18-26. PubMed ID: 28400200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalamic deep brain stimulation in the treatment of essential tremor.
    Mandat T; Koziara H; Rola R; Bonicki W; Nauman P
    Neurol Neurochir Pol; 2011; 45(1):37-41. PubMed ID: 21384292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal follow-up with VIM thalamic deep brain stimulation for dystonic or essential tremor.
    Tsuboi T; Jabarkheel Z; Zeilman PR; Barabas MJ; Foote KD; Okun MS; Wagle Shukla A
    Neurology; 2020 Mar; 94(10):e1073-e1084. PubMed ID: 32047071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a New Patient-Reported Outcome Measure of the Functional Impact of Essential Tremor on Activities of Daily Living.
    Shih LC; Stevenson MT; Bellows S; Fasano A; Kuo SH; Lyons KE; Moore H; Shill HA; Shukla AW; Singer C; Elble RJ
    Tremor Other Hyperkinet Mov (N Y); 2024; 14():26. PubMed ID: 38765931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of CX-8998, a Selective Modulator of the T-Type Calcium Channel in Inadequately Treated Moderate to Severe Essential Tremor: T-CALM Study Design and Methodology for Efficacy Endpoint and Digital Biomarker Selection.
    Papapetropoulos S; Lee MS; Boyer S; Newbold EJ
    Front Neurol; 2019; 10():597. PubMed ID: 31244760
    [No Abstract]   [Full Text] [Related]  

  • 18. Loss of long-term benefit from VIM-DBS in essential tremor: A secondary analysis of repeated measurements.
    Bai Y; Yin Z; Diao Y; Hu T; Yang A; Meng F; Zhang J
    CNS Neurosci Ther; 2022 Feb; 28(2):279-288. PubMed ID: 34866345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term benefits in quality of life after unilateral thalamic deep brain stimulation for essential tremor.
    Nazzaro JM; Pahwa R; Lyons KE
    J Neurosurg; 2012 Jul; 117(1):156-61. PubMed ID: 22519432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.